Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152201 | SCV000200958 | likely benign | not specified | 2014-02-27 | criteria provided, single submitter | clinical testing | p.Asn25373Asn in exon 275 of TTN: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. |
Gene |
RCV001697050 | SCV000716473 | likely benign | not provided | 2018-05-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000643412 | SCV000765099 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000152201 | SCV001482188 | likely benign | not specified | 2021-02-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345479 | SCV002653805 | likely benign | Cardiovascular phenotype | 2018-09-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |